The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial.
about
Utilization and Harmonization of Adult Accelerometry Data: Review and Expert ConsensusThe European Hematology Association Roadmap for European Hematology Research: a consensus documentInformation and Risk Modification Trial (INFORM): design of a randomised controlled trial of communicating different types of information about coronary heart disease risk, alongside lifestyle advice, to achieve change in health-related behaviourMutations in tropomyosin 4 underlie a rare form of human macrothrombocytopenia.Dawning of the age of genomics for platelet granule disorders: improving insight, diagnosis and management.From GWAS to function: lessons from blood cells.Recruitment and representativeness of blood donors in the INTERVAL randomised trial assessing varying inter-donation intervalsStatistical power considerations in genotype-based recall randomized controlled trials.The response to receiving phenotypic and genetic coronary heart disease risk scores and lifestyle advice - a qualitative study.The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.Donation frequency and its association with demographic characteristics--a 1-year observational study.Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopenia.Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders.Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.2016 European Conference on Donor Health and Management.Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms.Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.Getting personal with blood donors - the rationale for, methodology of and an overview of participants in the UK blood donor survey.NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease.Factors Associated With Engagement With a Web-Based Lifestyle Intervention Following Provision of Coronary Heart Disease Risk: Mixed Methods Study.Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors.Iron deficiency among blood donors: experience from the Danish Blood Donor Study and from the Copenhagen ferritin monitoring scheme.2014 European Conference on Donor Health and Management.Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies.Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing.Blood donation in the 21st century: time to celebrate?Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular diseaseCohort-wide deep whole genome sequencing and the allelic architecture of complex traits
P2860
Q26825109-84D7C9B5-33B8-404C-8594-8E3857CBA230Q28830861-EC939355-AD6F-4957-B1D2-42ECFB1C9C95Q30663945-BF1BB4CD-7687-4AD6-999E-03C86EB144F1Q30840174-228733AA-2B29-4E61-AD70-F55A6831DA45Q33437696-99DF2867-9691-4465-A77D-B036DF3414E3Q37027646-F80B0752-F998-41EB-9C1F-3A368E84FE78Q37267806-243F7435-D86D-4AEE-8321-DB05ED731007Q37438914-C657A177-62AC-4AE2-A02C-25C00CE5BAB7Q37470501-D3D44726-231D-4DD0-A370-6C62EB9D2F34Q37634534-32220BE4-F3DC-4B8B-87BA-F73BA691DCF8Q38924831-7BCA7719-DD50-4AF0-AD76-F1285A90A0E7Q39033939-8C38DB3D-22BF-45EB-9A73-42C3B8EFFD99Q39922110-158A24FC-660B-45D6-84F9-6BA8C6FE3890Q40068181-D5280ECB-E184-4592-A63E-AC8D26DB5E7BQ40084171-990E8910-DF5E-4BC3-9164-73201F882D3FQ40191164-245E2BEC-7E71-48BE-9CEA-9F394B9FE82FQ40418336-DDC60912-1192-49B3-8243-B79E57BC3FA1Q41016851-B4B9BF97-DC44-4A43-8E50-3AF4C34B7319Q46197743-1AE6D169-4100-4EAB-A089-815CC6258BCBQ46840974-2C709AD3-5898-4784-B69C-9B4118E5783EQ47099630-FB027B4F-C18A-453D-A5B5-0ABCAF607B93Q47599455-7BE166AF-2D98-483B-81A6-9B7A87CC6858Q47613820-EA963288-B77D-414C-A985-CA71EA40EEB7Q47652764-9426A572-B97D-4AC3-9135-980485DF4CABQ48133265-53E40E3E-0E32-4061-B283-676486C07100Q53340254-269FADA3-D87D-4646-A450-C74978C678A0Q57721581-8287B2E5-CE78-44AC-A300-2A91A43E3FB0Q58599719-5E73F636-B957-4757-8052-A3A0291979E3
P2860
The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The INTERVAL trial to determin ...... a randomised controlled trial.
@ast
The INTERVAL trial to determin ...... a randomised controlled trial.
@en
The INTERVAL trial to determin ...... a randomised controlled trial.
@nl
type
label
The INTERVAL trial to determin ...... a randomised controlled trial.
@ast
The INTERVAL trial to determin ...... a randomised controlled trial.
@en
The INTERVAL trial to determin ...... a randomised controlled trial.
@nl
prefLabel
The INTERVAL trial to determin ...... a randomised controlled trial.
@ast
The INTERVAL trial to determin ...... a randomised controlled trial.
@en
The INTERVAL trial to determin ...... a randomised controlled trial.
@nl
P2093
P2860
P50
P356
P1433
P1476
The INTERVAL trial to determin ...... a randomised controlled trial.
@en
P2093
Carmel Moore
David Allen
David J Roberts
Jennifer Sambrook
John Danesh
Matthew Walker
Simon G Thompson
Stephen Kaptoge
Susan Mehenny
Zoe Tolkien
P2860
P2888
P356
10.1186/1745-6215-15-363
P577
2014-09-17T00:00:00Z
P5875
P6179
1038320768